BioCentury | Apr 22, 2020
Product Development

FDA clears LabCorp’s COVID-19 home collection kits as Congress looks to bolster testing with $25B

LabCorp became the first diagnostic company to have an at-home collection kit for COVID-19 authorized by FDA, a month after the agency cleared its lab PCR test for the novel coronavirus. FDA also gave a...
BC Innovations | Jun 20, 2013
Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Neuropilin 2 (NRP2) Patient sample and mouse studies suggest inhibiting NRP2 could help prevent cancer metastasis. In multiple mouse xenograft models for human cancer,...
BC Innovations | Apr 17, 2008
Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Neuropilin 2 (NRP2) A study in cell culture and mice suggests that blocking NRP2 could be useful for inhibiting tumor...
Items per page:
1 - 3 of 3